What is Crigler-Najjar syndrome (Type I)?
Crigler-Najjar syndrome is a rare genetic syndrome that leads to the build-up of high levels of unconjugated bilirubin. This form of bilirubin is a toxic substance and causes the most serious symptoms of this syndrome.
There are two types of the syndrome: Type 1 is the severe form of the diseases, Type 2 is less severe and the symptoms are much milder.
Syndrome Synonyms:
Crigler-Najjar Syndrome; Hyperbilirubinemia, Crigler-Najjar Type I; HBLRCN1
What gene change causes Crigler-Najjar syndrome (Type 1)?
Mutations in the UGT1A1 gene are responsible for the syndrome. It is inherited in an autosomal recessive pattern.
Autosomal recessive inheritance means an affected individual receives one copy of a mutated gene from each of their parents, giving them two copies of a mutated gene. Parents, who carry only one copy of the gene mutation will not generally show any symptoms but have a 25% chance of passing the copies of the gene mutations onto each of their children.
What are the main symptoms of Crigler-Najjar syndrome (Type 1)?
The buildup of toxic unconjugated bilirubin in the blood can trigger kernicterus. This is a severe symptom in individuals with the Type 1 form of the syndrome. Kernicterus is a form of brain damage when the unconjugated bilirubin damages the nerves of the brain leading also to lethargy and hypotonia, as well as involuntary body movements, hearing issues and intellectual disability.
This buildup also causes jaundice, which is the yellowing of the skin and whites of the eyes.
Possible clinical traits/features:
Encephalopathy, Elevated hepatic transaminase, Hearing impairment, Memory impairment, Abnormality of the liver, Autosomal recessive inheritance, Seizure, Ophthalmoparesis, Jaundice, Kernicterus, Unconjugated hyperbilirubinemia.
How is it diagnosed?
To find out if someone has a diagnosis of Crigler-Najjar syndrome (Type 1), it is important to have a consultation and evaluation with a clinical genetic specialist. Specialists may also suggest specific genetic testing or other types of tests to help reach a diagnosis. FDNA’s AI technology can help speed up the diagnostic process by analyzing facial features and other health information.